Spectrum Innovation Act of 2021
Legislative Progress
Introduced
September 27, 2021
Latest Action
September 28, 2021
Primary Sponsor
Michael F. DoyleDemocratic(PA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Spectrum Innovation Act of 2021 This bill specifies a process for auctioning a portion of the electromagnetic spectrum between 3100 megahertz (MHz) and 3540 MHz for nonfederal use, shared federal and nonfederal use, or a combination of those uses. Most wireless technologies (e.g., mobile communication) rely on the electromagnetic spectrum to transmit signals. Specifically, the Office of Management and Budget must transfer funding from the Spectrum Reallocation Fund to federal entities for planning related to the reallocation. The National Telecommunications and Information Administration (NTIA) and the Executive Office of the President must oversee the planning. Informed by the planning, the Department of Commerce must identify at least 200 MHz of spectrum for reallocation. In identifying the spectrum, Commerce must consult with the Department of Defense, the Office of National Science and Technology Policy, and the Federal Communications Commission (FCC). The FCC must (1) adopt rules authorizing the use of the identified spectrum in consultation with the NTIA, and (2) auction licenses for the identified spectrum within seven years of the bill's enactment. Additionally, the President must modify or withdraw (subject to certain limits) current federal assignments of the identified spectrum to increase nonfederal use. The FCC must allow for opportunistic uses (i.e., allow devices to opportunistically identify and transmit on unused spectrum without infringing on the rights of the spectrum license holder) of a withdrawn or modified assignment. An allowed opportunistic use must cease after the auction if the use is inconsistent with the rights of the licensee that obtains its license through the auction.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (24)
Referred to the Subcommittee on Communications and Technology.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2025 · first_quarter · Health Issues
Monitor the following: Prescription Drug Supply Chain issues Pharmacy benefit manager policies 340B Reform related issues Telehealth related issues Native American health workforce development issues, generally FDA, Diagnostic Laboratory Testing issues Health Care Price Transparency H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives Surprise Billing Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
2024 · fourth_quarter · Health Issues
Issues related to drug pricing reform Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652/ HR2630 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. HR 5539 Orphan Cures Act HR 5547 Maintaining Investments in New Innovation Act S 3558 BIOSECURE Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) S Res 566 Cholesterol Education Month 2024 HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act. HR 5376 Share the Savings With Seniors Act S 3430 Mental Health, Lower Cost Drugs and Extenders Package. BIOCOMPETE (no bill number)- Issues related to prohibiting the export of biotechnology to certain foreign entities HR 8412 Clinical Trial Modernization Act S 5573 Skinny Labels, Big Savings Act HR 10515 American Relief Act
Client expense: $2,780,000 · Firm income: Not reported
2024 · fourth_quarter · Medicare/Medicaid
Issues related to drug pricing reform Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act HR 2534 PROTECT 340B act of 2023 HR 3561 the PATIENT act Issues related to cardiovascular disease awareness and treatment Issues related to ESRD Issues related to asthma and self-administered drug list Issues related to reimbursement for biologics/biosimilars Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S2407 Treat and Reduce Obesity Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 1542/HR 6283 DRUG Act S652 SAFE Step Act HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 S 2474/HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act HR 5547 Maintaining Investments in New Innovation Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act. HR 5376 Share the Savings With Seniors Act. S 3430 Mental Health, Lower Cost Drugs and Extenders Package HR 5539 Orphan Cures Act HR 10515 American Relief Act
2024 · fourth_quarter · Medicare/Medicaid
Monitor the following: H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $60,000
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $2,780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · third_quarter · Medicare/Medicaid
Issues related to drug pricing reform Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act HR 2534 PROTECT 340B act of 2023 HR 3561 the PATIENT act Issues related to cardiovascular disease awareness and treatment Issues related to ESRD Issues related to asthma and self-administered drug list Issues related to reimbursement for biologics/biosimilars Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S2407 Treat and Reduce Obesity Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 1542/HR 6283 DRUG Act S652 SAFE Step Act HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 S 2474/HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act HR 5547 Maintaining Investments in New Innovation Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act. HR 5376 Share the Savings With Seniors Act. S 3430 Mental Health, Lower Cost Drugs and Extenders Package HR 5539 Orphan Cures Act
Client expense: $2,770,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
Issues related to drug pricing reform Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652/ HR2630 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. HR 5539 Orphan Cures Act HR 5547 Maintaining Investments in New Innovation Act S 3558 BIOSECURE Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) S Res 566 Cholesterol Education Month 2024 HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act. HR 5376 Share the Savings With Seniors Act S 3430 Mental Health, Lower Cost Drugs and Extenders Package. BIOCOMPETE (no bill number)- Issues related to prohibiting the export of biotechnology to certain foreign entities HR 8412 Clinical Trial Modernization Act
Client expense: $2,770,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
Monitor the following: H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Monitor the following: FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
2024 · third_quarter · Health Issues
Monitor the following: FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
2024 · second_quarter · Health Issues
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542/ hr 6283 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. HR 5539 Orphan Cures Act HR 5547 Maintaining Investments in New Innovation Act S 3558 BIOSECURE Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) S Res 566 Cholesterol Education Month 2024 HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act . H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act . HR 5376 Share the Savings With Seniors Act . S 3430 Mental Health, Lower Cost Drugs and Extenders Package . BIOCOMPETE (no bill number)- Issues related to prohibiting the export of biotechnology to certain foreign entities
Client expense: $2,740,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medicare/Medicaid
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act HR 2534 PROTECT 340B act of 2023 HR 3561 the PATIENT act Issues related to cardiovascular disease awareness and treatment Issues related to ESRD Issues related to asthma and self-administered drug list Issues related to reimbursement for biologics/biosimilars Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S2407 Treat and Reduce Obesity Act S2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 1542/ HR 6283 DRUG Act S652 SAFE Step Act HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 S 2474/HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act HR 5547 Maintaining Investments in New Innovation Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act . H.R.8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net Act . HR 5376 Share the Savings With Seniors Act . S 3430 Mental Health, Lower Cost Drugs and Extenders Package . HR 5539 Orphan Cures Act
Client expense: $2,740,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medicare/Medicaid
Monitor the following: 340B Reform related issues, generally H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
2024 · second_quarter · Health Issues
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · first_quarter · Health Issues
Affordable Care Act (ACA); ACA tax credits; Telehealth flexibility; Mental Health Care; Health; site neutral payment reform; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP / Individual Market / ACA Exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity index factor; Employer-provided health coverage; Cyber Attack; Artificial Intelligence; H.R. 3838 - the Preventing Maternal Deaths Reauthorization Act of 2023, S. 1869- the Site-based Invoicing and Transparency Enhancement Act, H.R. 3417 - the Facilitating Accountability In Reimbursements Act (FAIR Act), H.R. 5378 - the Lower Costs, More Transparency Act, S. 1451 - the Healthy Competition for Better Care Act, H.R. 5376 - the Inflation Reduction Act of 2022,
Client expense: $1,810,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Network adequacy oversight, including Medicare Advantage plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Medicare Parts C and D prior authorization reforms, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act. Physician-led hospital barriers, including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act. Medicare physician fee schedule and sequestration relief, and Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor: (1) implementation of provisions in the Inflation Reduction Act of 2022 (P.L. 117-169), Subtitle B, Part 1, sec. (b), to modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) CMMI Medicare Part B drug demonstrations, including the Most Favored Nation demonstration.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
340B Reform related issues, generally Monitor the following: H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act HR 2534 PROTECT 340B act of 2023 HR 3561 the PATIENT act Issues related to cardiovascular disease awareness and treatment Issues related to ESRD Issues related to asthma and self-administered drug list Issues related to reimbursement for biologics/biosimilars Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S2407 Treat and Reduce Obesity Act S2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 1542 DRUG Act S652 SAFE Step Act HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 S 2474/HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act HR 5547 Maintaining Investments in New Innovation Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $3,330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Health Issues
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. HR 5539 Orphan Cures Act HR 5547 Maintaining Investments in New Innovation Act S 3558 BIOSECURE Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) S Res 566 Cholesterol Education Month 2024 HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $3,330,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Pharmacy
Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.5378 - Lower Costs, More Transparency Act - in support. S.2973 - Modernizing and Ensuring PBM Accountability Act - in support. Issues related to expanding out-of-pockets costs.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Health Issues
Healthcare research and development program related issues, generally H.R.5378, Lower Costs, More Transparency Act, Site neutral cut related issues Monitor the following: Public Health Services Act, generally Organ transplant issues Telehealth related issues Alabama Area Health Education Centers (AHEC) Laboratory Developed Tests Nurse reimbursement related issues Graduate Medical Education (GME) Hospital at Home Program, Entirety Proposed Cuts to OPPS for Organ Acquisition Cos Disproportionate Share Hospital (DSH) Payments NIH grant related issues Public health and CDC related issues Public Law 117-167, Supreme Court Security Funding Act of 2022, Division A--Creating Helpful Incentives to Produce Semiconductors (CHIPS Act), NSF and Energy related issues Agency for Healthcare Research and Quality related issues IDeA program related issues
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act HR 2534 PROTECT 340B act of 2023 HR 3561 the PATIENT act Issues related to cardiovascular disease awareness and treatment Issues related to ESRD Issues related to asthma and self-administered drug list Issues related to reimbursement for biologics/biosimilars Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S2407 Treat and Reduce Obesity Act S2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 1542 DRUG Act S652 SAFE Step Act HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 S 2474/HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act
Client expense: $3,550,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Health Issues
Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions.
Client expense: $3,550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms, including Medicare physician payment provisions in S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes. Network adequacy oversight, including Medicare Advantage plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Medicare Parts C and D prior authorization reforms, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act. Physician-led hospital barriers, including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act. Medicare physician fee schedule and sequestration relief, and Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor: (1) implementation of provisions in the Inflation Reduction Act of 2022 (P.L. 117-169), Subtitle B, Part 1, sec. (b), to modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) CMMI Medicare Part B drug demonstrations, including the Most Favored Nation demonstration.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
H.R.3290, 340B Transparency Act, Entirety 340B Reform related issues, generally Monitor the following: H.R.5378, Lower Cost More Transparency Act, Entirety Mental Health initiatives 340B generally American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · fourth_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues Monitor the following: H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
S 1339, Pharmacy Benefit Manager Reform Act-provisions related to disclosure, audits and PBM contracting. H.R. 3682 of the 117th Congress Improving Transparency to Lower Drugs Costs Act of 2021-provisions related to public disclosure of drug rebate and other data. Transparency in Coverage Final Rule (CMS-9915-F) provisions related to machine readable drug files. S. 3548 A bill to amend the Public Health Services Act to provide for hospital and insurer price transparency. H.R. 5378 Lower Costs, More Transparency Act provisions related to PBM transparency and disclosure requirements. S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Health Issues
H.R.5378, Lower Cost More Transparency Act, Entirety Monitor the following: H.R.3290, 340B Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · third_quarter · Medicare/Medicaid
H.R.5378, Lower Cost More Transparency Act, Entirety Monitor the following: H.R.3290, 340B Transparency Act, Entirety Mental Health initiatives 340B generally P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · third_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medical/Disease Research/Clinical Labs
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Recovery audit contractor reform. Medicare regulatory reform, including physician payment reforms. Network adequacy oversight. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Medicare Parts C and D prior authorization reforms, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act. Physician-led hospital barriers, including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act. Medicare physician fee schedule and sequestration relief. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor: (1) implementation of provisions in the Inflation Reduction Act of 2022 (P.L. 117-169), Subtitle B, Part 1, sec. (b), to modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) CMMI Medicare Part B drug demonstrations, including the Most Favored Nation demonstration.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Communications/Broadcasting/Radio/TV
HR 4521 & S. 1260 - America COMPETES Act/USICA (funding for Open RAN programs, CHIPS funding, and supply chain programs) HR 5378 - The Spectrum Innovation Act HR 3684 - Infrastructure Investment & Jobs Act S. 1541 - The Martha Wright Prison Phone Justice Act Federal Agency Spectrum Coordination Satellite licensing and safety (bill not introduced yet) National online privacy legislation (bill not introduced yet) IIJA Broadband Funding/Mapping Spectrum Auction Authority Extension (bill not introduced yet) Spectrum Coexistence Act 5G 5G Altimeter Interference Altimeter and CBand Spectrum hearing Criminal Justice Reform FirstNet Oversight Net Neutrality C-Band Deployment Spectrum Pipeline Broadband Affordability Rural Broadband ARP implementation Pole Attachments Privacy
Client expense: $2,997,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Communications/Broadcasting/Radio/TV
HR 4521 & S. 1260 - America COMPETES Act/USICA (funding for Open RAN programs, CHIPS funding, and supply chain programs) HR 5378 - The Spectrum Innovation Act HR 3684 - Infrastructure Investment & Jobs Act S. 1541 - The Martha Wright Prison Phone Justice Act Federal Agency Spectrum Coordination Satellite licensing and safety (bill not introduced yet) National online privacy legislation (bill not introduced yet) IIJA Broadband Funding/Mapping Spectrum Auction Authority Extension (bill not introduced yet) Spectrum Coexistence Act 5G 5G Altimeter Interference Altimeter and CBand Spectrum hearing Criminal Justice Reform FirstNet Oversight Net Neutrality C-Band Deployment Spectrum Pipeline Broadband Affordability Rural Broadband ARP implementation Pole Attachments Privacy
Client expense: $2,970,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Communications/Broadcasting/Radio/TV
-HR 4521 and S. 1260, America COMPETES Act/USICA (funding for Open RAN programs, CHIPS funding, and supply chain programs) -HR 5378 The Spectrum Innovation Act -S. 1472 Improving Spectrum Coordination Act -HR 5926 RESILIENT Networks Act -HR 678 The PHONE Act -HR 7783 Extending Americas Spectrum Auction Leadership Act of 2022 -S. 4117, HR 7624 Spectrum Innovation Act of 2022 -S. 3236, S. 2427 Reforming Broadband Connectivity Act of 2021 (USF Reform) -HR 8152 Privacy - the American Data Privacy and Protection Act (ADPPA) -S. 4865, HR 8858 - Digital Equity Foundation Act -S. 1472 - GRID Broadband Act -H.R. 2617 Consolidated Appropriations Act of 2023 -S. 5137-Rural Internet Improvement Act of 2022 -S. 5001- Tribal Connect Act of 2022 -Marian Wright-Reed Just and Reasonable Communications Act, S.1541 - Prison Phone Act -5G -C-Band Deployment/FAA Altimeter conflict -Spectrum Pipeline -Broadband Affordability -Broadband Regulation/Net Neutrality - Broadband deployment and affordability/Implementation of NTIA's BEAD program - Notice of Funding Opportunity - BroadbandUSA (BEAD NOFO)
Client expense: $3,040,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Communications/Broadcasting/Radio/TV
S 113 - BROWSER Act of 2021, all provisions. S 299 - SAFE TECH Act, all provisions. HR 1032 - Telecommunications Skilled Workforce Act, all provisions. HR 1043 - Proportional Reviews for Broadband Deployment Act, all provisions. HR 1044 - Broadband MAPS Act, all provisions. HR 1045 - Broadband Resiliency and Flexible Investment Act, all provisions. HR 1058 - Wireless Resiliency and Flexible Investment Act, all provisions. HR 1060 - WIRELESS Leadership Act, all provisions. HR 1061 - CABLE Expansion Act, all provisions. HR 1064 - Cable Transparency Act, all provisions. HR 1069 - Streamlining Permitting to Enable Efficient Deployment Broadband Infrastructure Act of 2021, all provisions. HR 1103 - CABLE Competition Act, all provisions. HR 1141 - Broadband Competition and Efficient Deployment Act, all provisions. HR 1149 - CONNECT Act, all provisions. HR 1056 - Wireless Broadband Competition and Efficient Deployment act, all provisions. HR 1156- Facilitating DIGITAL Applications Act, all provisions. S 436 - American Broadband Buildout Act, all provisions. PL 117-2 - American Rescue Plan Act of 2021, implementation of provisions related to broadband. HR 1362 - BOOST Act, all provisions. HR 1555 - Broadband Consumer Transparency Act of 2021, all provisions. S 553 - Government Spectrum Valuation Act, all provisions. S 608 - Keeping Critical Connections Act, all provisions. HR 1631 - Community Broadband Act, all provisions. HR 1650 - To require the Federal Communications Commission to study the current and projected demands on rural broadband networks associated with services offered by edge providers, and for other purposes, all provisions. HR 1672 - Connect America Act, all provisions. HR 1721 - To amend the Consolidated Appropriations Act, all provisions. HR 1781 - PROTECT Kids Act, all provisions. HR 1783 & S 745 - Accessible Affordable Internet for All Act, all provisions. HR 1841 & S2018- Digital Equity Act of 2021, all provisions. HR 1848 - LIFT America Act, all provisions. S 698 - HOTSPOTS Act, all provisions. S 724 - A bill to require the Federal Communications Commission to make the provision of Wi-Fi access on school buses eligible for E-rate support, provisions related to broadband. HR 1904 - Broadband Justice Act of 2021, all provisions. S 797 - PACT Act, provisions related to broadband. HR 2183 & S 922 - Eliminate the Digital Divide Act, all provisions. HR 1856 - Modern Television Act, all provisions. HR 3703 - Nationwide Dig Once Act, all provisions. S 2071 - BRIDGE Act of 2021, all provisions. HR 3369 - Broadband for Rural America Act, all provisions. HR 3435 - American Broadband Act, all provisions. HR 3376 - Expanding Opportunities for Broadband Deployment Act, all provisions. HR 3346 - No Rate Regulation of Broadband Internet Access Act, all provisions. S 741 - BIFIA, all provisions. S 1260 - United States Innovation and Competition Act of 2021, all provisions. S 2434 - Local Journalism Sustainability Act, provisions related to broadband. S 2473 - Middle Mile Broadband Deployment Act, all provisions. S 2499 - SAFE DATA Act, all provisions. S 2710 - Open App Markets Act, all provisions. S 2875 - Cyber Incident Reporting Act of 2021, all provisions. PL 117-58 - Infrastructure Investment and Jobs Act, implementation of provisions related to broadband. HR 4374 - Broadband Internet Connection for Rural America Act, all provisions. HR 4663 & S 2447 - SUCCESS Act, all provisions. HR 5056 - To amend the Internal Revenue Code of 1986 to provide tax credits for carriage of independent programmers by qualified distributors and multichannel video programming distributors, all provisions. HR 5378 - Spectrum Innovation Act of 2021, all provisions HR 5440 - Cyber Incident Reporting for Critical Infrastructure Act of 2021, all provisions. S 2911 - American Broadband Buildout to Eliminate America's Digital Divide Act of 2021, all provisions. HR 5596 - Justice Against Malicious Algorithms Act, provisions related to broadband. HR 6027- Online Privacy Act of 2021, provisions related to broadband. HR 6314 - Reforming the Broadband Connectivity Act of 2021, all provisions. S 2992 - American Innovation Choice and Online Act, provisions related to broadband. S 3042 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022, provisions related to broadband. S 3197 - Platform Competition and Opportunity Act of 2021, provisions related to broadband. S 3236 - Reforming the Broadband Connectivity Act of 2021, all provisions. HR 4521 - United States Innovation and Competition Act of 2021, provisions related to cybersecurity. HR 7060 & S 3587 - Connect Unserved Americans Act of 2022, all provisions. S 3663 - Kids Online Safety Act, all provisions. S 3600 - Strengthening American Cybersecurity Act of 2022, all provisions. S 1113 - Accelerating Rural Broadband Deployment Act, all provisions. HR 7624 & S 4117 - Spectrum Innovation Act, all provisions. HR 8152 - American Data Privacy and Protection Act, all provisions. HR 8254 - Financial Services and General Government Appropriations Act 2023, provisions related to broadband. HR 7900 - National Defense Authorization Act for Fiscal Year 2023, provisions related to spectrum. HR 7703 - CALM Modernization Act of 2022, all provisions. HR 8239 & S 4661 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2023, provisions related to broadband. PL 117-169 - Inflation Reduction Act of 2022, implementation of provisions related to taxes. HR 4521 - United States Innovation and Competition Act of 2021, provisions related to supply chain. HR 4350 & S 2792 - National Defense Authorization Act for Fiscal Year 2022, provisions related to spectrum and cybersecurity. HR 8573 & S 4676 - Net Neutrality and Broadband Justice Act, all provisions. HR 8575 - FAIR Contributions Act, provisions related to broadband. S 4763 - GRID Broadband Act of 2022, all provisions. HR 8679 & S 4767 - PLAN for Broadband Act, all provisions. H. Res. 1329, Recognizing the need for greater access to rural and agricultural media programming. S 5137 - Rural Internet Improvement Act of 2022, all provisions. HR 2617 - Consolidated Appropriations Act, 2023, provisions related to spectrum, broadband, and cybersecurity. Other issues pertaining to infrastructure and broadband investment, broadband adoption, video and telephone regulation, FCC merger review, diversity and inclusion, online privacy, cybersecurity, retransmission consent, channel carriage, spectrum and copyright.
Client expense: $2,810,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Appalachian Regional Commission, Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE
2022 · fourth_quarter · Telecommunications
-HR 205 - Accelerating Broadband Connectivity Act of 2021 - all provisions related to cable. -HR 474 - Protecting Consumer Information Act of 2021 - all provisions related to cable. -HR 847 - Promoting Digital Privacy Technologies Act - all provisions related to cable. -HR 1042 - Protecting Critical Infrastructure Act - all provisions related to cable. -HR 1044 - Broadband Measuring Availability and Aligning Policies Task Force (Broadband MAPS) Act - all provisions related to cable. -HR 1045 - Broadband Resiliency and Flexible Investment Act - all provisions related to cable. -HR 1046 - Federal Broadband Deployment in Unserved Areas Act - all provisions related to cable. -HR 1047 - Rural Broadband Permitting Efficiency Act of 2021 - all provisions related to cable. -HR 1049 - Expediting Federal Broadband Deployment Reviews Act - all provisions related to cable. -HR 1053 - TRUSTED Broadband Networks Act - all provisions related to cable. -HR 1055 - Federal Broadband Deployment Tracking Act - all provisions related to cable. -HR 1074 - Reducing Antiquated Permitting for Infrastructure Deployment (RAPID) Act - all provisions related to cable. -HR 1090 - Online Consumer Protection Act of 2021 - all provisions related to cable. -HR 1141 - Broadband Competition and Efficient Deployment Act - all provisions related to cable. -HR 1149 - Communities Overregulating Networks Need Economic Competition Today (CONNECT) Act - all provisions related to cable. -HR 1555 - Broadband Consumer Transparency Act of 2021 - all provisions related to cable. -HR 1631 - Community Broadband Act - all provisions related to cable. -HR 1650 - Rural Broadband Network Study Act - all provisions related to cable. -HR 1672 - Connect America Act - all provisions related to cable. -HR 1781 - Preventing Real Online Threats Endangering Children Today (PROTECT) Kids Act - all provisions related to cable. -HR 1783 - Accessible, Affordable Internet for All Act - all provisions related to cable. -HR 1841 - Digital Equity Act of 2021- all provisions related to cable. -HR 2183 - Eliminate the Digital Divide Act - all provisions related to cable. -HR 2400 - Community Broadband Mapping Act - all provisions related to cable. -HR 2411 - Broadband for All Act of 2021 - all provisions related to cable. -HR 2501 - Spectrum Coordination Act - all provisions related to cable. -HR 2617 - Consolidated Appropriations Act, 2023 - all provisions related to cable. -HR 2665 - Local Telecom Expansion Act of 2021 - all provisions related to cable. -HR 2667 - Broadband Equipment Rental Reform Act - all provisions related to cable. -HR 2668 - Consumer Protection and Relief Act - all provisions related to cable. -HR 3067 - Online Consumer Protection Act (OCPA) - all provisions related to cable. -HR 3346 - No Rate Regulation of Broadband Internet Access Act - all provisions related to cable. -HR 3369 - Broadband for Rural America Act - all provisions related to cable. -HR 3376 - Expanding Opportunities for Broadband Deployment Act - all provisions related to cable. -HR 3435 - American Broadband Act - all provisions related to cable. -HR 3816 - American Choice and Innovation Online Act - all provisions related to cable. -HR 3849 - Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS) Act of 2021 - all provisions related to cable. -HR 4374 - Broadband Internet Connections for Rural America Act - all provisions related to cable. -HR 4383 - Reprioritizing Unserved Rural Areas and Locations for Broadband Act of 2021 - all provisions related to cable. -HR 4521 - America COMPETES Act of 2022 - all provisions related to cable. -HR 4659 - BROWSER Act of 2021 - all provisions related to cable. -HR 4663 - Securing Universal Communications Connectivity to Ensure Students Succeed Act - all provisions related to cable. -HR 4801 - Kids PRIVCY Act - all provisions related to cable. -HR 4825 - 21st Century Broadband Deployment Act - all provisions related to cable. -HR 4875 - Anti Digital Redlining Act of 2021 - all provisions related to cable. -HR 4905 - Big Tech Accountability for Broadband Act - all provisions related to cable. -HR 5257 - Device Access for Every American Act - all provisions related to cable. -HR 5378 - Spectrum Innovation Act of 2021 - all provisions related to cable. -HR 5400 - Preventing Disruptions to Universal Service Funds Act - all provisions related to cable. -HR 5439 - Kids Internet Design and Safety (KIDS) Act - all provisions related to cable. -HR 5512 - RURAL Broadband Mapping Act - all provisions related to cable. -HR 5596 - Justice Against Malicious Algorithms Act of 2021 - all provisions related to cable. -HR 5803 - PROMISE Act - all provisions related to cable. -HR 5807 - DATA Privacy Act - all provisions related to cable. -HR 5836 - Enhancing DIVERSITY Data Act - all provisions related to cable. -HR 5871 - American Telecommunications Security Act - all provisions related to cable. -HR 5874 - Restoring Americas Leadership in Innovation Act of 2021 - all provisions related to cable. -HR 6027 - Online Privacy Act of 2021 - all provisions related to cable. -HR 6314 - Reforming Broadband Connectivity Act of 2021 - all provisions related to cable. -HR 6359 - Investing in Domestic Semiconductor Manufacturing Act - all provisions related to cable. -HR 6373 - To establish the Digital Literacy and Equity Commission, and for other purposes - all provisions related to cable. -HR 6544 - EARN IT Act of 2022 - all provisions related to cable. -HR 7060 - Connect Unserved Americans Act of 2022 - all provisions related to cable. -HR 7101 - Prohibiting Anticompetitive Mergers Act of 2022 - all provisions related to cable. -HR 7624 - Spectrum Innovation Act of 2022 - all provisions related to cable. -HR 7858 - Digital Platform Commission Act of 2022 - all provisions related to cable. -HR 8077 - Closing the Digital Divide for Students Act of 2022 - all provisions related to cable. -HR 8099 - Encouraging Private Investment for Better Broadband Act - all provisions related to cable. -HR 8152 - American Data Privacy and Protection Act - all provisions related to cable. -HR 8239 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023 - all provisions related to cable. -HR 8254 - Financial Services and General Government Appropriations Act, 2023 - all provisions related to cable. -HR 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 - all provisions related to cable. -HR 8257 - Department of Homeland Security Appropriations Act, 2023 - all provisions related to cable. -HR 8573 - Net Neutrality and Broadband Justice Act of 2022 - all provisions related to cable. -HR 8575 - FAIR Contributions Act - all provisions related to cable. -HR 8679 - PLAN for Broadband Act - all provisions related to cable. -HR 9333 - Communications, Video, and Technology Accessibility Act of 2022 - all provisions related to cable. -HR 9343 - Tribal Connect Act of 2022 - all provisions related to cable. -HR 9445 - ACCESS Rural America Act - all provisions related to cable. -HRes 1329 - Recognizing the need for greater access to rural and agricultural media programming - all provisions related to cable. -S 113 - Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 - all provisions related to cable. -S 163 - Telecommunications Skilled Workforce Act - all provisions related to cable. -S 224 - Promoting Digital Privacy Technologies Act - all provisions related to cable. -S 225 - Competition and Antitrust Law Enforcement Reform Act of 2021 - all provisions related to cable. -S 228 - Merger Filing Fee Modernization Act of 2021 - all provisions related to cable. -S 233 - Assisting Broadband Connectivity Act of 2021 - all provisions related to cable. -S 279 - National Broadband Plan for the Future Act of 2021 - all provisions related to cable. -S 326 - Measuring the Economic Impact of Broadband Act of 2021 - all provisions related to cable. -S 553 - Government Spectrum Valuation Act - all provisions related to cable. -S 592 - Broadband Reserve Fund Act - all provisions related to cable. -S 608 - Keeping Critical Connections Act - all provisions related to cable. -S 741 - Broadband Infrastructure Finance Innovation Act (BIFIA) - all provisions related to cable. -S 745 - Accessible, Affordable Internet for All Act - all provisions related to cable. -S 797 - Platform Accountability and Consumer Transparency (PACT) Act - all provisions related to cable. -S 919 - Data Care Act - all provisions related to cable. -S 922 - Eliminate the Digital Divide Act - all provisions related to cable. -S 1113 - Accelerating Rural Broadband Deployment Act - all provisions related to cable. -S 1381 - Every Child Connected Act - all provisions related to cable. -S 1423 - Clean Slate for Kids Online Act - all provisions related to cable. -S 1460 - Community Broadband Act of 2021 - all provisions related to cable. -S 1472 - Improving Spectrum Coordination Act of 2021 - all provisions related to cable. -S 1494 - Consumer Data Privacy and Security Act - all provisions related to cable. -S 1563 - Telecommunications Supply Chain Diversity Promotion Act - all provisions related to cable. -S 1628 - Children and Teens Online Privacy Protection Act - all provisions related to cable. -S 1667 - Social Media Privacy Protection and Consumer Rights Act - all provisions related to cable. -S 1885 - Rural Connectivity Advancement Program Act of 2021 - all provisions related to cable. -S 1896 - Algorithmic Justice and Online Platform Transparency Act of 2021 - all provisions related to cable. -S 2071 - Broadband Reform and Investment to Drive Growth in the Economy (BRIDGE) Act of 2021 - all provisions related to cable. -S 2228 - DISCOURSE Act - all provisions related to cable. -S 2335 - Dont Push My Buttons Act - all provisions related to cable. -S 2447 - Securing Universal Communications Connectivity to Ensure Students Succeed Act - all provisions related to cable. -S 2473 - Middle Mile Broadband Deployment Act - all provisions related to cable. -S 2499 - Setting an American Framework to Ensure Data Access, Transparency, and Accountability Act (SAFE DATA Act) - all provisions related to cable. -S 2668 - A bill to require the Office of Internet Connectivity and Growth at the National Telecommunications and Information Administration to provide assistance relating to broadband access, and for other purposes - all provisions related to cable. -S 2729 - Device Access for Every American Act - all provisions related to cable. -S 2911 - American Broadband Buildout to Eliminate Americas Digital Divide Act of 2021 - all provisions related to cable. -S 2918 - Kids Internet Design and Safety (KIDS) Act - all provisions related to cable. -S 2972 - A bill to repeal section 230 of the Communications Act of 1934 - all provisions related to cable. -S 2979 - NTIA Policy and Cybersecurity Coordination Act - all provisions related to cable. -S 2992 - American Innovation and Choice Online Act - all provisions related to cable. -S 3014 - Next Generation Telecommunications Act - all provisions related to cable. -S 3029 - Protecting Americans from Dangerous Algorithms Act - all provisions related to cable. -S 3065 - DATA Privacy Act - all provisions related to cable. -S 3195 - Consumer Online Privacy Rights Act - all provisions related to cable. -S 3197 - Platform Competition and Opportunity Act of 2021 - all provisions related to cable. -S 3208 - Supply Chain Resiliency Act - all provisions related to cable. -S 3236 - Reforming Broadband Connectivity Act of 2021 - all provisions related to cable. -S 3288 - NTIA Reauthorization and Reform Act of 2021 - all provisions related to cable. -S 3309 - Securing Semiconductor Supply Chains Act of 2021 - all provisions related to cable. -S 3331 - Investing in Domestic Semiconductor Manufacturing Act - all provisions related to cable. -S 3501 - Terms-of-service Labeling, Design and Readability Act - all provisions related to cable. -S 3538 - EARN IT Act of 2022 - all provisions related to cable. -S 3663 - Kids Online Safety Act - all provisions related to cable. -S 3671 - Broadband Buildout Accountability Act - all provisions related to cable. -S 3777 - SHIELD Act of 2022 - all provisions related to cable. -S 3847 - Prohibiting Anticompetitive Mergers Act of 2022 - all provisions related to cable. -S 3880 - SMART Copyright Act of 2022 - all provisions related to cable. -S 4117 - Spectrum Innovation Act of 2022 - all provisions related to cable. -S 4126 - Rural Broadband Protection Act of 2022 - all provisions related to cable. -S 4201 - Digital Platform Commission Act of 2022 - all provisions related to cable. -S 4258 - Competition and Transparency in Digital Advertising Act - all provisions related to cable. -S 4309 - ACCESS Act of 2022 - all provisions related to cable. -S 4661 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023 - all provisions related to cable. -S 4664 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 - all provisions related to cable. -S 4763 - GRID Broadband Act of 2022 - all provisions related to cable. -S 4767 - PLAN for Broadband Act - all provisions related to cable. -S 4820 - Protecting Communications Networks from Chinese Communist Party Espionage Act - all provisions related to cable. -S 5121 - Communications, Video, and Technology Accessibility Act of 2022 - all provisions related to cable. -S 5137 - Rural Internet Improvement Act of 2022 - all provisions related to cable.
Client expense: $4,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE
2022 · fourth_quarter · Telecommunications
General lobbying communications on the following issues: availability and appropriate uses of commercial wireless spectrum; integrity and security of communications networks; an appropriate regulatory framework for Internet and communications services; broadband availability and pricing; universal service; infrastructure investment and development, including pole replacement costs; data management; privacy; media ownership and Freedom of the Press; location-based services; telecommunications supply chain security; implementation of the Nationwide Broadband Public Safety Network operated by the First Responder Network Authority; legislation designed to streamline broadband infrastructure deployment and permit placement of wireless tower facilities on federal property; the deployment of 5G communication services and worldwide services to enterprise customers; and spectrum policy. Lobbying on the following bills: S. 113 - BROWSER Act, all provisions; S. 592 - Broadband Reserve Fund Act, all provisions; S. 698 - Hotspots and Online Technology and Services Procurement for our Tribes and States (HOTSPOTS) Act, all provisions; S. 1472 - Improving Spectrum Coordination Act, all provisions; S. 1494 - Consumer Data Privacy and Security Act, provisions related to obligations of Internet Service Providers; S. 2407 - Cyber Incident Notification Act of 2021, all provisions; S. 3014 - Next Generation Telecommunications Act, provisions related to the creation of a 6G advisory council; S. 3195 - Consumer Online Privacy Rights Act, all provisions; S. 3663 - Kids Online Safety Act, all provisions; S. 4117/H.R. 7624 - Spectrum Innovation Act, all provisions; S. 4590 - Uncap America Act, all provisions; S. 4865/H.R. 8857, Digital Equity Act, all provisions; P.L. 117-2 - American Rescue Act, implementation provisions; P.L. 117-58 - Infrastructure Investment and Jobs Act, implementation provisions; H.R. 678 Preserving Home and Office Numbers in Emergencies (PHONE) Act, all provisions; H.R. 963 - Forced Arbitration Injustice Relief (FAIR) Act, provisions relating to limiting the use of pre-dispute arbitration clauses in employment contracts and consumer contracts; H.R. 1046 - Federal Broadband Deployment in Unserved Areas Act, all provisions; H.R. 1047 - Rural Broadband Permitting Efficiency Act, all provisions; H.R. 1053 - Timely Replacement Under Secure and Trusted for Early and Dependable Broadband Networks Act (TRUSTED Broadband Networks) Act, all provisions; H.R. 1056 - Wireless Broadband Competition and Efficient Deployment Act, all provisions; H.R. 1058 - Wireless Resiliency and Flexible Investment Act, all provisions; H.R. 1060 - Winning the International Race for Economic Leadership and Expanding Service to Support Leadership (WIRELESS Leadership) Act; H.R. 1069 - Streamlining Permitting to Enable Efficient Deployment of Broadband Infrastructure (SPEED) Act, all provisions; H.R. 1074 - Reducing Antiquated Permitting for Infrastructure Deployment (RAPID) Act, all provisions; H.R. 1149 - Communities Overregulating Networks Need Economic Competition Today (CONNECT) Act, all provisions; H.R. 1251 - Cyber Diplomacy Act, all provisions; H.R. 1816 - Information Transparency and Personal Data Control Act, all provisions; H.R. 1856 - Modern Television Act, all provisions; H.R. 1934 - Promoting U.S. International Leadership in 5G, all provisions; H.R. 2617 - Consolidated Appropriations Act of 2023, Title IX, Extension of FCC Auction Authority; H.R. 2685 - Understanding Cybersecurity of Mobile Networks Act, provisions related to supply chain security and cybersecurity; H.R. 3346 - No Rate Regulation of Broadband Internet Access Act, all provisions H.R. 3524 - EAGLE Act, provisions related to international standards and supply chain security; H.R. 3703 - Nationwide Dig Once Act, all provisions;*H.R. 4028 - Information and Communications Technology Strategy Act, provisions related to supply chain security and cybersecurity; H.R. 4028 - Information and Communication Technology Strategy Act, provisions related to supply chain security and cybersecurity; H.R. 4029 - Timely Evaluation of Acquisitions, Mergers, or Transactions with External, Lawful Entities to Clear Owners and Management Act, provisions related to foreign investment screening; H.R. 4045 - Future Uses of Technology Upholding Reliable and Enhanced Networks Act, provisions related to supply chain security and cybersecurity; H.R. 4046 - NTIA Policy and Cybersecurity Coordination Act, provisions related to supply chain security and cybersecurity; H.R. 4055 - American Cybersecurity Literacy Act, provisions related to supply chain security and cybersecurity; H.R. 4067 - Communications Security Act of 2021, provisions related to supply chain security and cybersecurity; H.R. 5378 - Spectrum Innovation Act, all provisions; H.R. 5486 - SMART ACT, all provisions; H.R. 5491 - Securing Systemically Important Critical Infrastructure Act, all provisions; H.R. 7766 - James M. Inhofe National Defense Authorization Act for FY 2023, provision related to cybersecurity, 5G development and deployment, supply chain security, spectrum policy and federal contracting; H.R. 7783 - Extending Americas Spectrum Auction Leadership Act, all provisions; H.R. 8152 - American Data Privacy and Protection Act, all provisions; Draft reinforcing and Evaluating Service Integrity, Local Infrastructure, and Emergency Notification for Todays Networks Act, issues related to wireless network resiliency and disaster recovery; H.R. 8573/S. 4676 - Net Neutrality and Broadband Justice Act, all provisions; H.R. 8575 - Funding Affordable Internet with Reliable (FAIR) Contributions Act; and Draft Reinforcing and Evaluating Service Integrity, Local Infrastructure, and Emergency Notification for Todays Networks Act, issues related to wireless network resiliency and disaster recovery.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Telecommunications
Issues pertaining to federal spectrum policy; H.R. 5378/S. 4417 Spectrum Innovation Act of 2021; H.R. 2617, Consolidated Appropriations Act 2023
Client expense: Not reported · Firm income: $60,000
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Telecommunications
H.R. 2501 - Spectrum Coordination Act H.R. 4990 - ITS Codification Act H.R. 5378 - Spectrum Innovation Act of 2021 H.R. 5486 - SMART Act H.R. 7132 - Safe Connections Act of 2022 H.R. 7624 - Spectrum Innovation Act of 2022 H.R. 7783 - Extending Americas Spectrum Auction Leadership Act of 2022 H.R. 8152 - American Data Privacy and Protection Act Issues related to 988 implementation Issues related to auction authority extension Issues related to C-band/altimeters Issues related to comprehensive privacy protections Issues related to contraband prison phones Issues related to cybersecurity Issues related to data breach and data security Issues related to E911/NG911 Issues related to ensuring federal broadband awards are not taxable Issues related to net neutrality Issues related to oversight of the Federal Communications Commission Issues related to oversight of the National Telecommunications and Information Administration Issues related to resiliency Issues related to robocalls Issues related to semi-conductors Issues related to spectrum policy Issues related to stolen phones Issues related to tax treatment of spectrum swaps Issues related to the book minimum tax on spectrum Issues related to the deployment of broadband Issues related to the deployment of wireless infrastructure Issues related to wireless emergency alerts S. 120 - Safe Connections Act of 2021 S. 1472 - Improving Spectrum Coordination Act of 2021 S. 3014 - Next Generation Telecommunications Act S. 4117 - Spectrum Innovation Act of 2022 S. 4409 - Political BIAS Emails Act of 2022
Client expense: $2,770,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Telecommunications
General lobbying communications on the following issues: availability and appropriate uses of commercial wireless spectrum; integrity and security of communications networks; appropriate regulatory framework for Internet and communications services; broadband availability and pricing; universal service; infrastructure investment and development, including pole replacement costs; data management; privacy; media ownership and Freedom of the Press; location-based services; telecommunications supply chain security; implementation of the Nationwide Broadband Public Safety Network operated by the First Responder Network Authority; sunset of the 3G network; legislation designed to streamline broadband infrastructure deployment and permit placement of wireless tower facilities on federal property; the deployment of 5G communication services and worldwide services to enterprise customers; and spectrum policy. Lobbying on the following bills: S. 113 - BROWSER Act, all provisions; S. 120/H.R. 7132 - Safe Connections Act, all provisions; S. 592 - Broadband Reserve Fund Act, all provisions; S. 698 - Hotspots and Online Technology and Services Procurement for our Tribes and States (HOTSPOTS) Act, all provisions; S. 1472 - Improving Spectrum Coordination Act, all provisions; S. 1472 - Improving Spectrum Coordination Act, all provisions; S. 1494 - Consumer Data Privacy and Security Act, provisions related to obligations of Internet Service Providers; S. 2407 - Cyber Incident Notification Act of 2021, all provisions; S. 3014 - Next Generation Telecommunications Act, provisions related to creation of 6G advisory council; S. 3195 - Consumer Online Privacy Rights Act, all provisions; S. 3663 - Kids Online Safety Act, all provisions; S. 4590 - Uncap America Act, all provisions; P.L. 117-2 - American Rescue Act, implementation provisions; P.L. 117-58 - Infrastructure Investment and Jobs Act, implementation provisions; H.R. 678 Preserving Home and Office Numbers in Emergencies (PHONE) Act, all provisions; H.R. 963 - Forced Arbitration Injustice Relief (FAIR) Act, provisions relating to limiting the use of pre-dispute arbitration clauses in employment contracts and consumer contracts; H.R. 1046 - Federal Broadband Deployment in Unserved Areas Act, all provisions; H.R. 1047 - Rural Broadband Permitting Efficiency Act, all provisions; H.R. 1053 - Timely Replacement Under Secure and Trusted for Early and Dependable Broadband Networks Act (TRUSTED Broadband Networks) Act, all provisions; H.R. 1056 - Wireless Broadband Competition and Efficient Deployment Act, all provisions; H.R. 1058 - Wireless Resiliency and Flexible Investment Act, all provisions; H.R. 1060 - Winning the International Race for Economic Leadership and Expanding Service to Support Leadership (WIRELESS Leadership) Act; H.R. 1069 - Streamlining Permitting to Enable Efficient Deployment of Broadband Infrastructure (SPEED) Act, all provisions; H.R. 1074 - Reducing Antiquated Permitting for Infrastructure Deployment (RAPID) Act, all provisions; H.R. 1149 - Communities Overregulating Networks Need Economic Competition Today (CONNECT) Act, all provisions; H.R. 1251 - Cyber Diplomacy Act, all provisions; H.R. 1816 - Information Transparency and Personal Data Control Act, all provisions; H.R. 1856 - Modern Television Act, all provisions; H.R. 1934 - Promoting U.S. International Leadership in 5G, all provisions; H.R. 2685 - Understanding Cybersecurity of Mobile Networks Act, provisions related to supply chain security and cybersecurity; H.R. 3346 - No Rate Regulation of Broadband Internet Access Act, all provisions H.R. 3524 - EAGLE Act, provisions related to international standards and supply chain security; H.R. 3703 - Nationwide Dig Once Act, all provisions;*H.R. 4028 - Information and Communications Technology Strategy Act, provisions related to supply chain security and cybersecurity; H.R. 4028 - Information and Communication Technology Strategy Act, provisions related to supply chain security and cybersecurity; H.R. 4029 - Timely Evaluation of Acquisitions, Mergers, or Transactions with External, Lawful Entities to Clear Owners and Management Act, provisions related to foreign investment screening; H.R. 4045 - Future Uses of Technology Upholding Reliable and Enhanced Networks Act, provisions related to supply chain security and cybersecurity; H.R. 4046 - NTIA Policy and Cybersecurity Coordination Act, provisions related to supply chain security and cybersecurity; H.R. 4055 - American Cybersecurity Literacy Act, provisions related to supply chain security and cybersecurity; H.R. 4067 - Communications Security Act of 2021, provisions related to supply chain security and cybersecurity; H.R. 5378 - Spectrum Innovation Act, all provisions; H.R. 5486 - SMART ACT, all provisions; H.R. 5491 - Securing Systemically Important Critical Infrastructure Act, all provisions; H.R. 7624/S. 4117 - Spectrum Innovation Act, all provisions; H.R. 7783 - Extending Americas Spectrum Auction Leadership Act, all provisions; H.R. 7900 - National Defense Authorization Act for FY 2023, provisions related to cybersecurity, 5G development and deployment, supply chain security, spectrum policy and federal contracting; H.R. 8152 - American Data Privacy and Protection Act, all provisions; Draft reinforcing and Evaluating Service Integrity, Local Infrastructure, and Emergency Notification for Todays Networks Act, issues related to wireless network resiliency and disaster recovery; H.R. 8573/S. 4676 - Net Neutrality and Broadband Justice Act, all provisions; H.R. 8575 - Funding Affordable Internet with Reliable (FAIR) Contributions Act; and Draft, Reinforcing and Evaluating Service Integrity, Local Infrastructure, and Emergency Notification for Todays Networks Act, issues related to wireless network resiliency and disaster recovery.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE